Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Testosterone therapy lacks evidence for preventing muscle loss, bone fractures, heart disease, or cognitive decline in women.

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...

Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

MBS significantly reduces liver-related complications and other health risks in patients with SLD, including cardiovascular, ...

Panelists discuss how schizophrenia presents a wide spectrum of symptoms categorized into positive, negative, and cognitive ...

Panelists discuss how schizophrenia’s immense personal and financial burden calls for early, integrated, and sustained care ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and ...